Back to 
TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP
NKTR5 quarters
Position history for TWO SIGMA INVESTMENTS, LP's holdings in NEKTAR THERAPEUTICS
Yes. Two Sigma holds 1,202,004 shares of NKTR (Nektar Therapeutics), worth $83.9M, as of its Q2 2026 13F filing. It increased the position by 271,263 shares (+29.1%) from Q1 2026. Two Sigma has held NKTR in every 13F on record since Q2 2025, 5 quarterly filings. NKTR is 0.1% of Two Sigma's reported 13F portfolio.
Current Value
$83.9M
Current Shares
1.2M
Total Value Change
+$81.9M
Total Shares Change
+1.1M
Quarter-by-Quarter History
Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC